(Q48467637)

English

Randomised, double-blind study of the effects of oxybutynin, tolterodine, trospium chloride and placebo on sleep in healthy young volunteers

scientific article published in January 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/17535050

Randomised, double-blind study of the effects of oxybutynin, tolterodine, trospium chloride and placebo on sleep in healthy young volunteers (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/17535050

Klaus-Dieter Wernecke

5

object named as

Klaus-Dieter Wernecke

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/17535050

author name string

Konstanze Diefenbach

1

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/17535050

Frank Donath

2

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/17535050

Agathe Maurer

3

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/17535050

Sabine Quispe Bravo

4

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/17535050

Ulrich Schwantes

6

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/17535050

Jutta Haselmann

7

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/17535050

Ivar Roots

8

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/17535050

publication date

1 January 2003

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/17535050

Clinical Drug Investigation

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/17535050

23

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/17535050

6

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/17535050

395-404

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/17535050

Randomized, double-blind, multicenter trial on treatment of frequency, urgency and incontinence related to detrusor hyperactivity: oxybutynin versus propantheline versus placebo

1 reference

https://pubmed.ncbi.nlm.nih.gov/17535050

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The treatment of detrusor instability in post-menopausal women with oxybutynin chloride: a double blind placebo controlled study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17535050

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification of medications that cause cognitive impairment in older people: the case of oxybutynin chloride

1 reference

https://pubmed.ncbi.nlm.nih.gov/17535050

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Statistical comparison of multiple dependent samples--the Friedman test and the Wilcoxon and Wilcox Dij test]

1 reference

https://pubmed.ncbi.nlm.nih.gov/17535050

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Importance of pharmacological and physicochemical properties for tolerance of antimuscarinic drugs in the treatment of detrusor instability and detrusor hyperreflexia--chances for improvement of therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/17535050

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of repeated doses of scopolamine on the electroencephalographic stages of sleep in normal volunteers

1 reference

https://pubmed.ncbi.nlm.nih.gov/17535050

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic opportunities from muscarinic receptor research

1 reference

https://pubmed.ncbi.nlm.nih.gov/17535050

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acetylcholine and the regulation of REM sleep: basic mechanisms and clinical implications for affective illness and narcolepsy

1 reference

https://pubmed.ncbi.nlm.nih.gov/17535050

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidemiology and etiology of urinary incontinence in the elderly

1 reference

https://pubmed.ncbi.nlm.nih.gov/17535050

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New adverse effect of oxybutynin: "night terror".

1 reference

https://pubmed.ncbi.nlm.nih.gov/17535050

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Proposed supplements and amendments to 'A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects', the Rechtschaffen & Kales (1968) standard

1 reference

https://pubmed.ncbi.nlm.nih.gov/17535050

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influences of trospium chloride and oxybutynin on quantitative EEG in healthy volunteers

1 reference

https://pubmed.ncbi.nlm.nih.gov/17535050

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical efficacy and safety of tolterodine in the treatment of overactive bladder: a pooled analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17535050

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Trospium chloride: an effective option for medical treatment of bladder overactivity.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17535050

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of biperiden and bornaprine on sleep in healthy subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/17535050

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Experimental acceleration and slowing of REM sleep ultradian rhythm by cholinergic agonist and antagonist

1 reference

https://pubmed.ncbi.nlm.nih.gov/17535050

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sleep in depression: the influence of age, gender and diagnostic subtype on baseline sleep and the cholinergic REM induction test with RS 86.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17535050

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tolterodine, a new antimuscarinic drug for treatment of bladder overactivity

1 reference

https://pubmed.ncbi.nlm.nih.gov/17535050

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Neuropsychiatric adverse effects attributed to use of oxybutynin]

1 reference

https://pubmed.ncbi.nlm.nih.gov/17535050

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cholinergic antagonists and REM sleep generation

1 reference

https://pubmed.ncbi.nlm.nih.gov/17535050

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differential effects of scopolamine on nocturnal cortisol secretion, sleep architecture, and REM latency in normal volunteers: relation to sleep and cortisol abnormalities in depression.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17535050

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of trospium chloride in patients with detrusor instability: a placebo-controlled, randomized, double-blind, multicentre clinical trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/17535050

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Muscarinic receptor antagonists in the treatment of overactive bladder

1 reference

https://pubmed.ncbi.nlm.nih.gov/17535050

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sleep electroencephalographic abnormalities in adolescent depressives: effects of scopolamine

1 reference

https://pubmed.ncbi.nlm.nih.gov/17535050

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oxybutynin and cognitive dysfunction

1 reference

https://pubmed.ncbi.nlm.nih.gov/17535050

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00044011-200323060-00003

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/17535050

release_mar5pmeuzbhjfhct2x5rvbdgta

1 reference

https://api.fatcat.wiki/v0/release/mar5pmeuzbhjfhct2x5rvbdgta

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/17535050

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48467637&oldid=2199653006"